Imunon, Inc. Quarterly Deferred Income Tax Expense (Benefit) in USD from Q1 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Imunon, Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2020 to Q1 2024.
  • Imunon, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $1.28M, a 18.3% decline year-over-year.
  • Imunon, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was $287K.
  • Imunon, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was -$184K, a 140% decline from 2021.
  • Imunon, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was $462K.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.28M -$287K -18.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q1 2023 $1.57M +$184K +13.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q1 2022 $1.38M -$462K -25.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $1.85M +$26.5K +1.46% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q1 2020 $1.82M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.